Ozempic (semaglutide) and other GLP-1 medications have helped many people lose weight and manage chronic conditions like type ...

Weight-loss patients voice concerns as CVS Caremark drops Zepbound coverage for Wegovy, though exceptions may exist for those ...

Eli Lilly will soon bring a pill version to the market, with a version expected to debut at a lower price than injectable ...

The diabetes drugs Ozempic and Wegovy have been linked to an increased risk of sudden vision loss and blindness due to a rare ...

A new analysis of 11 global studies shows that people tend to regain lost weight after stopping anti-obesity medications like ...

Restaurants across the U.S. are introducing “Ozempic menus” with smaller, protein-rich portions to cater to millions using ...

The study found that GLP-1 medications, in particular, showed significant weight regain after treatment discontinuation.

The overarching commonality is that there isn't one: "Not all people experiences the same degree of facial and body changes ...

As of 2024, Brazil's Semaglutide market was estimated at $581 million. The global market size for the GLP-1 (glucagon-like ...

What happens when you stop taking Ozempic®? There’s no one-size-fits-all answer to this question. When you stop taking ...

Paul Curran, MPharm, a clinical pharmacist with Optimal You in the UK, says there is one nasty side effect, in particular, ...

Several anti-obesity drugs, including Ozempic, Wegovy and Mounjaro, have created buzz in the Indian markets. But are they really approved for use in India? What are their side-effects? And how much do ...